TW200509903A - A method of purifying moxidectin through crystallization - Google Patents
A method of purifying moxidectin through crystallizationInfo
- Publication number
- TW200509903A TW200509903A TW093123351A TW93123351A TW200509903A TW 200509903 A TW200509903 A TW 200509903A TW 093123351 A TW093123351 A TW 093123351A TW 93123351 A TW93123351 A TW 93123351A TW 200509903 A TW200509903 A TW 200509903A
- Authority
- TW
- Taiwan
- Prior art keywords
- moxidectin
- crystallization
- purifying
- purifying moxidectin
- macrolide
- Prior art date
Links
- YZBLFMPOMVTDJY-CBYMMZEQSA-N moxidectin Chemical compound O1[C@H](C(\C)=C\C(C)C)[C@@H](C)C(=N/OC)\C[C@@]11O[C@H](C\C=C(C)\C[C@@H](C)\C=C\C=C/2[C@]3([C@H](C(=O)O4)C=C(C)[C@@H](O)[C@H]3OC\2)O)C[C@H]4C1 YZBLFMPOMVTDJY-CBYMMZEQSA-N 0.000 title abstract 3
- 229960004816 moxidectin Drugs 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 2
- 238000002425 crystallisation Methods 0.000 title 1
- 230000008025 crystallization Effects 0.000 title 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 239000003120 macrolide antibiotic agent Substances 0.000 abstract 1
- 244000045947 parasite Species 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/22—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/14—Ectoparasiticides, e.g. scabicides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/12—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains three hetero rings
- C07D493/14—Ortho-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49331703P | 2003-08-07 | 2003-08-07 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| TW200509903A true TW200509903A (en) | 2005-03-16 |
| TWI343254B TWI343254B (en) | 2011-06-11 |
Family
ID=33552111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW093123351A TWI343254B (en) | 2003-08-07 | 2004-08-04 | A method of purifying moxidectin through crystallization |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US7348417B2 (zh) |
| EP (1) | EP1505069B1 (zh) |
| JP (1) | JP4653979B2 (zh) |
| KR (1) | KR101123018B1 (zh) |
| CN (1) | CN100439375C (zh) |
| CY (1) | CY1113198T1 (zh) |
| DK (1) | DK1505069T3 (zh) |
| ES (1) | ES2387390T3 (zh) |
| PL (1) | PL1505069T3 (zh) |
| PT (1) | PT1505069E (zh) |
| SI (1) | SI1505069T1 (zh) |
| TW (1) | TWI343254B (zh) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010065852A1 (en) | 2008-12-04 | 2010-06-10 | Merial Limited | Dimeric avermectin and milbemycin derivatives |
| CA2784141C (en) | 2009-12-17 | 2017-10-24 | Merial Limited | Compositions comprising macrocyclic lactone compounds and spirodioxepinoindoles |
| PL3351546T3 (pl) * | 2011-12-02 | 2024-09-09 | Boehringer Ingelheim Vetmedica Gmbh | Długodziałające wstrzykiwalne postaci moksydektyny |
| NZ712345A (en) | 2013-04-12 | 2016-04-29 | Zoetis Services Llc | Composition of macrocyclic lactones, levamisole, an amino sugar and an additional antiparasitic agent |
| CN103601735B (zh) * | 2013-11-08 | 2015-12-09 | 大连九信生物化工科技有限公司 | 一种提纯莫西克汀的方法 |
| KR101484481B1 (ko) * | 2014-08-07 | 2015-01-20 | 주식회사 다림바이오텍 | Pde-5 저해제를 포함하는 설하분무제의 제조방법 및 이에 의하여 제조된 설하분무용 조성물 |
| CN105001232A (zh) * | 2015-07-08 | 2015-10-28 | 安徽省皖北药业股份有限公司 | 一种莫昔克丁的提纯方法 |
| CN105646521B (zh) * | 2016-03-28 | 2018-10-02 | 河北圣雪大成制药有限责任公司 | 一种莫西克汀的结晶方法 |
| CN107383053B (zh) * | 2017-07-25 | 2019-11-05 | 宁夏泰瑞制药股份有限公司 | 一种莫西菌素粗品的纯化方法 |
| KR102412089B1 (ko) * | 2021-09-13 | 2022-06-22 | 주식회사 세라수 | Dmts의 정제방법 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5317030A (en) * | 1984-06-05 | 1994-05-31 | American Cyanamid Company | Method and compositions for helmintic, arthropod ectoparasitic and acaridal infections with novel agents |
| US5106994A (en) * | 1984-06-05 | 1992-04-21 | American Cyanamid Company | Agents and method of production thereof |
| US5169956A (en) * | 1984-06-05 | 1992-12-08 | American Cyanamid Company | Macrolide antibiotic compounds |
| US5198464A (en) * | 1984-06-05 | 1993-03-30 | American Cyanamid Company | Method and compositions for helmintic, arthropod ectoparasitic and acaridal infections with novel agents |
| CA1296329C (en) * | 1986-06-06 | 1992-02-25 | Derek R. Sutherland | Macrolide compounds |
| US4916154A (en) * | 1986-09-12 | 1990-04-10 | American Cyanamid Company | 23-Imino derivatives of LL-F28249 compounds |
| US4988824A (en) * | 1989-09-11 | 1991-01-29 | Maulding Donald R | Process for the preparation of 23-(C1-C6 alkyloxime)-LL-F28249 compounds |
| US5478951A (en) * | 1994-06-22 | 1995-12-26 | American Cyanamid Company | Method for the purification of 23-E isomers of 23-imino derivatives of LL-F28249 compounds |
-
2004
- 2004-07-20 US US10/894,965 patent/US7348417B2/en not_active Expired - Fee Related
- 2004-07-30 DK DK04254592.1T patent/DK1505069T3/da active
- 2004-07-30 SI SI200431894T patent/SI1505069T1/sl unknown
- 2004-07-30 EP EP04254592A patent/EP1505069B1/en not_active Expired - Lifetime
- 2004-07-30 PT PT04254592T patent/PT1505069E/pt unknown
- 2004-07-30 ES ES04254592T patent/ES2387390T3/es not_active Expired - Lifetime
- 2004-07-30 PL PL04254592T patent/PL1505069T3/pl unknown
- 2004-08-04 TW TW093123351A patent/TWI343254B/zh not_active IP Right Cessation
- 2004-08-05 JP JP2004229533A patent/JP4653979B2/ja not_active Expired - Fee Related
- 2004-08-06 KR KR1020040062045A patent/KR101123018B1/ko not_active Expired - Fee Related
- 2004-08-06 CN CNB2004100684407A patent/CN100439375C/zh not_active Expired - Lifetime
-
2008
- 2008-01-29 US US12/021,429 patent/US7645863B2/en not_active Expired - Fee Related
-
2012
- 2012-08-06 CY CY20121100701T patent/CY1113198T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP4653979B2 (ja) | 2011-03-16 |
| TWI343254B (en) | 2011-06-11 |
| CN100439375C (zh) | 2008-12-03 |
| KR101123018B1 (ko) | 2012-03-15 |
| PL1505069T3 (pl) | 2012-12-31 |
| PT1505069E (pt) | 2012-08-07 |
| EP1505069B1 (en) | 2012-07-04 |
| EP1505069A1 (en) | 2005-02-09 |
| CY1113198T1 (el) | 2016-04-13 |
| US20080119543A1 (en) | 2008-05-22 |
| KR20050016205A (ko) | 2005-02-21 |
| DK1505069T3 (da) | 2012-07-23 |
| US7348417B2 (en) | 2008-03-25 |
| US20050033041A1 (en) | 2005-02-10 |
| ES2387390T3 (es) | 2012-09-21 |
| CN1626536A (zh) | 2005-06-15 |
| JP2005053916A (ja) | 2005-03-03 |
| US7645863B2 (en) | 2010-01-12 |
| SI1505069T1 (sl) | 2012-08-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1113198T1 (el) | Μεθοδος καθαρισμου της μοξιδεκτινης μεσω κρυσταλλωσης | |
| AU2003223110A1 (en) | System and method for the treatment of wastewater using plants | |
| NO20055251D0 (no) | Lotterisystem og fremgangsmate med sanntidsvoksende jackpot | |
| AU2002368274A8 (en) | Methods of treating infection by drug resistant bacteria | |
| GB0608318D0 (en) | Biologically active reactor system and method for treating wastewater | |
| NO20050134D0 (no) | Difenylazetidioner substituert med syregrupper, fremgangsmate for fremstilling av disse, medikamenter inneholdende disse forbindelser og deres anvendelse | |
| ATE531419T1 (de) | Vorrichtung zur verabreichung von therapeutischen mitteln | |
| AU2002354439A1 (en) | Nanocarbon-dissolving aqueous solution, aqueous solution for purification, and method of purification | |
| FR2864696B1 (fr) | Masque de laser et procede de cristallisation utilisant le masque | |
| ATE344262T1 (de) | 2-heteroarylcarbonsäureamide | |
| AP2001002051A0 (en) | Phosphorous organic compounds and their use. | |
| NO20043598L (no) | Fremgangsmate og anlegg for biologisk behandling av vannholdige utslipp for rensing av samme | |
| PL371081A1 (pl) | Preparat farmaceutyczny wpływający na procesy wzrostu i mineralizacji układu kostno-szkieletowego oraz chorób kości i chrząstki wieku dojrzałego u ludzi i zwierząt oraz zastosowanie preparatu farmaceutycznego w procesie wzrostu i mineralizacji układu kostno-szkieletowego oraz chorób kości i chrząstki wieku dojrzałego u ludzi i zwierząt | |
| TR200402230T4 (tr) | O-ikameli 6-metil-tramadol-türevleri | |
| FR2816330B1 (fr) | Monocristaux, procede de fabrication de monocristaux par croissance en solution et applications | |
| WO2003024996A3 (de) | Antibakterielle makrozyklen | |
| AU2003258176A8 (en) | Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases | |
| ATE269858T1 (de) | Kristallines oder kristallisiertes säureadditionssalz von losartan und verfahren zur reinigung von losartan | |
| Webb | What are the benefits and the pitfalls of preoperative fasting? | |
| EP1270728A4 (en) | METHOD FOR PRODUCING AVERMECTIN DERIVATIVES | |
| AU5482001A (en) | Method for producing caprolactam on the basis of 6-aminocapronitrile and subsequent purification by crystallization | |
| DE60315666D1 (de) | Furopyridin- und furopyrimidinderivate zur behandlung von hyperproliferativen erkrankungen | |
| AU2003300616A1 (en) | Method and device for reducing sludge production at treatment plants | |
| NO20051094D0 (no) | Fremgangsmate for styrt, maskinell bearbeidelse av hodekappet og renset hvitfisk, og innretning for gjennomforing av fremgangsmaten | |
| ZA200203809B (en) | Method and plant for treatment of process water. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | Annulment or lapse of patent due to non-payment of fees |